# Middle East Pharmaceutical Industries Company (4016.SR): MoatMap facts

As of 7 Nov 2026. Research data, not investment advice.

As of 7 Nov 2026, the MoatMap Score for Middle East Pharmaceutical Industries Company (4016.SR) is 80/100, ranked against 25,000+ stocks in 38 markets (Quality 78, Value 32, Momentum 67, each scored against its sector).

- MoatMap Score: 80/100, a percentile across 25,000+ stocks in 38 markets (100 is best).
- Quality 78, Value 32, Momentum 67: each a 0-100 percentile within Healthcare.
- Position: #5,370 overall, #593 in Healthcare.
- Listing: Saudi Arabia, SAU; Healthcare / Drug Manufacturers - Specialty & Generic.
- Last close: 64.8 SAR on 5 Nov 2026.

Source: https://moatmap.ai/stock/4016.SR
How the scores work: https://moatmap.ai/methodology
Does the score work? Each tenth of the ranking is tracked monthly: https://moatmap.ai/decile-tracker